Insider Buying and Selling - REPL

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
12/02/2025 10b5-1	12/04/2025	Patel Sushil Chief Executive Officer CEO Director	Sell	-10,000 @ $11.13	($111,300.00)	333,576	(-2.91%)	Direct
11/17/2025	11/19/2025	Sarchi Christopher Chief Commercial Officer Officer	Sell	-5,208 @ $9.10	($47,392.80)	123,088	(-4.06%)	Direct
11/17/2025	11/19/2025	Xynos Konstantinos Chief Medical Officer Officer	Sell	-7,248 @ $9.10	($65,956.80)	139,685	(-4.93%)	Direct
08/15/2025	08/19/2025	Hill Emily Luisa Chief Financial Officer CFO	Sell	-9,154 @ $5.37	($49,156.98)	134,368	(-6.38%)	Direct
05/20/2025	05/22/2025	Astley-Sparke Philip Director	Sell	-32,279 @ $8.06	($260,168.74)	1,405,071	(-2.25%)	Direct
05/20/2025	05/22/2025	Hill Emily Luisa Chief Financial Officer CFO	Sell	-2,535 @ $8.05	($20,406.75)	143,522	(-1.74%)	Direct
05/20/2025	05/22/2025	Patel Sushil Chief Executive Officer CEO Director	Sell	-25,105 @ $8.06	($202,346.30)	343,576	(-6.81%)	Direct
05/20/2025	05/22/2025	Sarchi Christopher Chief Commercial Officer Officer	Sell	-3,749 @ $8.05	($30,179.45)	128,296	(-2.84%)	Direct
05/20/2025	05/22/2025	Schwendenman Andrew Chief Accounting Officer Officer	Sell	-3,287 @ $8.05	($26,460.35)	68,284	(-4.59%)	Direct
05/20/2025	05/22/2025	Xynos Konstantinos Chief Medical Officer Officer	Sell	-7,952 @ $8.06	($64,093.12)	146,933	(-5.13%)	Direct
12/16/2024 10b5-1	12/18/2024	Patel Sushil Chief Executive Officer CEO Director	Sell	-10,000 @ $12.42	($124,200.00)	202,014	(-4.72%)	Direct

Replimune Group, Inc. - REPL